Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Sandu Pharmaceuticals Ltd Performance

Today's Low
58.50
arrowIcon
Today's High
61.74
52 Wk Low
49.00
arrowIcon
52 Wk High
85.00


Open

61.5

Traded Value (Cr)

2.13 L

Prev. Close

61.3

VWAP

60.24

Volume

3,604

Face Value

10

Sandu Pharmaceuticals Ltd Fundamentals

Market Cap
₹ 59 Cr
P/E Ratio (TTM)
51.95
P/B Ratio
1.89
Debt to Equity
0.00
ROE
3.51 %
EPS (TTM)
1.18
Dividend Yield
0.00%
Book Value
32.52

Click here to know more about Fundamentals

Sandu Pharmaceuticals Ltd Financials

Sandu Pharmaceuticals Ltd Financials

Sandu Pharmaceuticals Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 44.16 % 45.19 % 45.29 % 35.70 %
Promoters 42.90 % 42.90 % 42.90 % 52.41 %
Others 12.93 % 11.91 % 11.81 % 11.88 %
FII 0.00 % 0.00 % 0.00 % 0.00 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %

Retail

44.16%

Promoters

42.90%

Others

12.93%

FII

0.00%

Mutual Funds

0.00%

Retail

45.19%

Promoters

42.90%

Others

11.91%

FII

0.00%

Mutual Funds

0.00%

Retail

45.29%

Promoters

42.90%

Others

11.81%

FII

0.00%

Mutual Funds

0.00%

Retail

35.70%

Promoters

52.41%

Others

11.88%

FII

0.00%

Mutual Funds

0.00%

Resistance and Support

₹61.66

PIVOT

resistance-arrow
Resistance
First Resistance₹62.027
Second Resistance₹62.753
Third Resistance₹63.117
support-arrow
Support
First Resistance₹60.937
Second Resistance₹60.573
Third Resistance₹59.847
RSI40.781
MACD-1.359
ADX16.948
CCI-168.742

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day9403,04384.43
Week1,7781,48086.72
1 Month2,6122,10285.55
6 Months000.00

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97. Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.

Managing Director

Umesh B Sandu

Founded

1985

NSE Symbol

Sandu Pharmaceuticals Ltd Management

NameDesignation
Dilip R SalgaocarNon-Exec. & Independent Dir.
Krishna B DeshpandeNon-Exec. & Independent Dir.
Madan Laxman KapreNon-Exec. & Independent Dir.
K Vinay KumarChairman & Independent Directo
Shashank B SanduNon-Exec & Non-Independent Dir
Umesh B SanduManaging Director
Shubhada P SanduNon-Exec & Non-Independent Dir
Pratika MhambrayCompany Sec. & Compli. Officer

Sandu Pharmaceuticals Ltd News

Sandu Pharmaceuticals schedules board meeting
On 30 March 2024
Sandu Pharmaceuticals to discuss results
On 14 February 2024
Sandu Pharmaceuticals consolidated net profit declines 8.33% in the September 2023 quarter
Sales decline 0.89% to Rs 16.61 crore
Sandu Pharmaceuticals to conduct board meeting
On 13 November 2023
Sandu Pharmaceuticals to convene AGM
On 30 September 2023
Board of Sandu Pharmaceuticals recommends Final Dividend
Of Rs.0.75 per share
Sandu Pharmaceuticals consolidated net profit declines 35.29% in the June 2023 quarter
Sales rise 8.81% to Rs 17.66 crore
Sandu Pharmaceuticals to discuss results
On 14 August 2023
Sandu Pharmaceuticals reports consolidated net profit of Rs 0.27 crore in the March 2023 quarter
Sales rise 33.63% to Rs 15.26 crore
Sandu Pharmaceuticals reports standalone net profit of Rs 0.27 crore in the March 2023 quarter
Sales rise 33.63% to Rs 15.26 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
SUNPHARMA₹ 3,58,304 Cr
₹ 1,493.35
(-1.85 %)
86.97
CIPLA₹ 1,09,708 Cr
₹ 1,358.80
(-1.88 %)
33.36
DIVISLAB₹ 1,00,599 Cr
₹ 3,789.50
(-3.55 %)
73.75
DRREDDY₹ 98,073 Cr
₹ 5,879.05
(-2.93 %)
22.59
ZYDUSLIFE₹ 97,383 Cr
₹ 967.80
(-3.77 %)
36.23

Sandu Pharmaceuticals Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Sandu Pharmaceuticals Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Sandu Pharmaceuticals Ltd's share price is ₹59.01 as of May 9, 2024

Sandu Pharmaceuticals Ltd's P/E ratio is 51.95 times as of May 9, 2024.

Sandu Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 1.89, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Sandu Pharmaceuticals Ltd's market is 59 Cr as on May 9, 2024.

The current financial records of Sandu Pharmaceuticals Ltd show a 3.51% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Sandu Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Sandu Pharmaceuticals Ltd's 52-week high and low as of May 9, 2024 are ₹61.74 and ₹58.5 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Sandu Pharmaceuticals Ltd stands at 42.90%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.